CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer...
CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients
About this item
Full title
Author / Creator
Publisher
Melbourne, Australia: Blackwell Publishing Asia
Journal title
Language
English
Formats
Publication information
Publisher
Melbourne, Australia: Blackwell Publishing Asia
Subjects
More information
Scope and Contents
Contents
The present study aimed to identify polymorphic genes encoding carbonyl reductases (CBR1, CBR3) and investigate their influence on doxorubicin disposition in Asian breast cancer patients (n = 62). Doxorubicin (60 mg/m2) was administered every 3 weeks for four to six cycles and the pharmacokinetic parameters were estimated using non‐compartmental an...
Alternative Titles
Full title
CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11160041
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11160041
Other Identifiers
ISSN
1347-9032,0910-5050,1349-7006
E-ISSN
1349-7006
DOI
10.1111/j.1349-7006.2008.00903.x
